P577 Cost-effectiveness of episodic or maintenance infliximab versus standard treatment in an incidence cohort of Crohn's disease patients with 10-years follow-up | Zendy

AI Assistant Blog Pricing

P577 Cost-effectiveness of episodic or maintenance infliximab versus standard treatment in an incidence cohort of Crohn's disease patients with 10-years follow-up

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.